- Home
- NCL vs ALUR Comparison
NCL vs ALUR Comparison
Compare NCL & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCL
- ALUR
- Stock Information
- Founded
- NCL 2013
- ALUR 2009
- Country
- NCL United States
- ALUR United States
- Employees
- NCL N/A
- ALUR N/A
- Industry
- NCL
- ALUR
- Sector
- NCL
- ALUR
- Exchange
- NCL Nasdaq
- ALUR Nasdaq
- Market Cap
- NCL 21.7M
- ALUR 18.0M
- IPO Year
- NCL 2023
- ALUR N/A
- Fundamental
- Price
- NCL $0.19
- ALUR $3.02
- Analyst Decision
- NCL
- ALUR Strong Buy
- Analyst Count
- NCL 0
- ALUR 3
- Target Price
- NCL N/A
- ALUR $22.83
- AVG Volume (30 Days)
- NCL 3.4M
- ALUR 213.4K
- Earning Date
- NCL 08-13-2025
- ALUR 08-12-2025
- Dividend Yield
- NCL N/A
- ALUR N/A
- EPS Growth
- NCL N/A
- ALUR N/A
- EPS
- NCL N/A
- ALUR N/A
- Revenue
- NCL $14,192,050.00
- ALUR $28,304,000.00
- Revenue This Year
- NCL N/A
- ALUR N/A
- Revenue Next Year
- NCL N/A
- ALUR $49.37
- P/E Ratio
- NCL N/A
- ALUR N/A
- Revenue Growth
- NCL N/A
- ALUR N/A
- 52 Week Low
- NCL $0.15
- ALUR $2.15
- 52 Week High
- NCL $1.52
- ALUR $22.63
- Technical
- Relative Strength Index (RSI)
- NCL 42.03
- ALUR 55.72
- Support Level
- NCL $0.17
- ALUR $3.05
- Resistance Level
- NCL $0.21
- ALUR $3.33
- Average True Range (ATR)
- NCL 0.01
- ALUR 0.23
- MACD
- NCL 0.02
- ALUR 0.02
- Stochastic Oscillator
- NCL 62.27
- ALUR 63.49
About NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.